Although biosimilars may be years away from their US debut, now is the time for pharmacists to educate themselves on this new class of agents so that they will be prepared to provide support for their appropriate use.
Steven Lucio, PharmD, BCPS
Advertisement
Articles by Steven Lucio, PharmD, BCPS
Advertisement
Latest Updated Articles
- Biosimilars: Where Are They Now?
April 17th 2014
Advertisement
Advertisement
Trending on Pharmacy Times
1
Staging the Heart: NLA and EAS Reveal a New Era of Precision Lipidology and Imaging
2
ATTR-CM Red Flags, Treatment Evidence, and the Pharmacist's Role in Care
3
FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant Treatment of High-Risk Clear Cell RCC
4
A Paradigm Shift in Lipid Management: Highlights from the NLA 2026 Scientific Sessions Opening Session
5